- Antiplate Agents
-
Chae SC
- KMID: 1938824
- Korean Circ J.
- 2002 Oct;32(10):851-855.
- doi: 10.4070/kcj.2002.32.10.851
The role of platelets in atherogenesis, acute coronary syndrome and the development of complications from percutaneous coronary intervention is relatively well known. Until recently, aspirin was the only antiplatelet agent... -
- CITED
-
- Close
- SHARE
-
- Close
- New Oral Antiplatelet Agents
-
Kang MK, Chang K
- KMID: 2267821
- Korean J Med.
- 2013 Jul;85(1):10-14.
Antiplatelet agents play an essential role in the treatment of acute coronary syndrome (ACS). Aspirin and thienopyridines comprise the major classes of antiplatelet therapies demonstrated to be of benefit in... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemolytic Uremic Syndrome with Clopidogrel after Coronary Angioplasty
-
Park SH, Park JH, Park SY, Lee EJ, Jun HS, Kim YH, Kim YW
- KMID: 2258899
- Korean J Med.
- 2011 Jun;80(Suppl 2):S253-S257.
Thienopyridines are antiplatelet agents used in post-percutaneous coronary angioplasty patients and patients with acute coronary syndrome, stroke, and peripheral arterial disease. Ticlopidine has been shown to reduce the incidence of... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation
-
Chin N, Rangamuwa , Mariasoosai R, Carnes J, Thien F
- KMID: 2397068
- Asia Pac Allergy.
- 2015 Jan;5(1):51-54.
- doi: 10.5415/apallergy.2015.5.1.51
Oral platelet aggregation inhibitors are widely used for the treatment and prevention of cardiovascular diseases, including coronary stent thrombosis. Premature discontinuation following percutaneous coronary intervention would pose a grave risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiplatelet Agents in High-Risk Patients with Coronary Artery Disease
-
Chae SC
- KMID: 1938849
- Korean Circ J.
- 2004 Jan;34(1):23-27.
- doi: 10.4070/kcj.2004.34.1.23
The role of platelets is well known in the atherogenesis, acute coronary syndrome and development of complications of percutaneous coronary intervention. Until recently, aspirin was the only antiplatelet agent available... -
- CITED
-
- Close
- SHARE
-
- Close
